Cargando…
Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
Coronavirus disease 2019 (COVID-19) infection causes acute lung injury, resulting from aggressive inflammation initiated by viral replication. There has been much speculation about the potential role of non-steroidal inflammatory drugs (NSAIDs), which increase the expression of angiotensin-convertin...
Autores principales: | Bruce, Eilidh, Barlow-Pay, Fenella, Short, Roxanna, Vilches-Moraga, Arturo, Price, Angeline, McGovern, Aine, Braude, Philip, Stechman, Michael J., Moug, Susan, McCarthy, Kathryn, Hewitt, Jonathan, Carter, Ben, Myint, Phyo Kyaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465199/ https://www.ncbi.nlm.nih.gov/pubmed/32785086 http://dx.doi.org/10.3390/jcm9082586 |
Ejemplares similares
-
Routine use of immunosuppressants is associated with mortality in hospitalised patients with COVID-19
por: Myint, Phyo K., et al.
Publicado: (2021) -
Study protocol for the COPE study: COVID-19 in Older PEople: the influence of frailty and multimorbidity on survival. A multicentre, European observational study
por: Price, Angeline, et al.
Publicado: (2020) -
The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
por: Braude, Philip, et al.
Publicado: (2020) -
The Clinical Frailty Scale: Estimating the Prevalence of Frailty in Older Patients Hospitalised with COVID-19. The COPE Study
por: Collins, Jemima T., et al.
Publicado: (2020) -
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
por: Hewitt, Jonathan, et al.
Publicado: (2020)